A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

Clinical trial NCT03990363 · COMPLETED

Trial details

NCT number: NCT03990363
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2019-07-23
Primary completion: 2021-11-22
Enrollment: 861

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.